search
Back to results

Motivation Matters Study (MM)

Primary Purpose

HIV/AIDS

Status
Completed
Phase
Not Applicable
Locations
Kenya
Study Type
Interventional
Intervention
Individualized, interactive short messaging intervention
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for HIV/AIDS focused on measuring ART, mobile messaging, behaviour, motivation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • More than 18 years or emancipated minor
  • Has access to mobile phone
  • Self-identifying female sex worker
  • Willing to receive study SMS messages
  • HIV-positive (any WHO stage or CD4)
  • Able to read or have someone else read
  • ART naïve
  • Informed consent obtained and signed.

Exclusion Criteria:

  • Plans to move away in next 6 months
  • Contraindication to ART

Sites / Locations

  • Women's Health Project, Mombasa

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Individualized, interactive SMS

Standard care

Arm Description

Individualized, interactive SMS intervention plus Standard care. Messages sent automatically using the Text-IT system.

Standard care according to Kenyan guidelines, including clinic-based adherence education and counseling.

Outcomes

Primary Outcome Measures

Plasma HIV-1 viral load
The plasma HIV-1 viral load will be compared between participants in the intervention and in the non-intervention arm.

Secondary Outcome Measures

Full Information

First Posted
December 8, 2015
Last Updated
November 2, 2020
Sponsor
University of Washington
Collaborators
University of Nairobi, Kenya Medical Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT02627365
Brief Title
Motivation Matters Study
Acronym
MM
Official Title
Motivation Matters! Randomized Clinical Trial of Theory Based SMS to Support Treatment as Prevention in High-Risk Women
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
January 2016 (undefined)
Primary Completion Date
August 2018 (Actual)
Study Completion Date
August 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
University of Nairobi, Kenya Medical Research Institute

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The study aims to develop and evaluate the efficacy and causal mechanisms of an interactive SMS intervention to optimize individual health and secondary HIV prevention benefits of ART in HIV-positive FSWs.
Detailed Description
Antiretroviral therapy (ART) is highly effective at reducing the infectiousness of HIV-positive people, and is considered the cornerstone of all new HIV prevention approaches. A critical question is how to harness the potency of ART to reduce transmission from female sex workers (FSWs), a key population that has been central to HIV transmission in Africa for more than 25 years. In high prevalence countries like Kenya, FSWs represent about 1% of the population, yet contribute to one in seven (14%) new HIV infections. Targeting treatment as prevention (TasP) to FSWs could efficiently reduce HIV transmission on a population level. Effective TasP will require higher levels of ART adherence than those achieved in typical treatment programs. The rapid spread of mobile technology in Africa provides unique opportunities for mobile health (mHealth) interventions, which have been shown to be acceptable to providers and patients, and can improve ART adherence and suppression of plasma HIV viral load. The ability of mobile (SMS) interventions to support ART adherence in key populations like FSWs and unique clinical scenarios such as TasP has yet to be evaluated. The investigators will answer these fundamental questions by addressing the following aims: 1) To use a qualitative rapid assessment and development approach to craft a theory-based, individualized, interactive SMS intervention, grounded in the Theory of Information, Motivation, and Behavior (IMB), to support ART adherence in HIV-positive FSWs, 2) To compare individualized, interactive SMS to standard care in achieving undetectable HIV VL 6 months post ART initiation in a randomized controlled trial (RCT) with 210 FSWs and 3) To administer an adaptation of the LifeWindows Information - Motivation - Behavioral Skills ART Adherence Questionnaire (LW-IMB-AAQ) to understand the mechanism of our SMS intervention's effect by comparing perceptions of support and motivation to adhere to ART in FSWs who received the intervention versus standard care. Our overarching goal is to develop and evaluate the efficacy and causal mechanisms of an interactive SMS intervention to optimize individual health and secondary HIV prevention benefits of ART in HIV-positive FSWs. The aims of this project proceed sequentially from developmental (Aim 1) through implementation of the intervention (Aim 2) to evaluation of the fit with the behavioral model (Aim 3).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS
Keywords
ART, mobile messaging, behaviour, motivation

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
119 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Individualized, interactive SMS
Arm Type
Experimental
Arm Description
Individualized, interactive SMS intervention plus Standard care. Messages sent automatically using the Text-IT system.
Arm Title
Standard care
Arm Type
No Intervention
Arm Description
Standard care according to Kenyan guidelines, including clinic-based adherence education and counseling.
Intervention Type
Behavioral
Intervention Name(s)
Individualized, interactive short messaging intervention
Intervention Description
An Individualized, interactive short messaging intervention reminding study participants to take antiretroviral medication and report any problems.
Primary Outcome Measure Information:
Title
Plasma HIV-1 viral load
Description
The plasma HIV-1 viral load will be compared between participants in the intervention and in the non-intervention arm.
Time Frame
six months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: More than 18 years or emancipated minor Has access to mobile phone Self-identifying female sex worker Willing to receive study SMS messages HIV-positive (any WHO stage or CD4) Able to read or have someone else read ART naïve Informed consent obtained and signed. Exclusion Criteria: Plans to move away in next 6 months Contraindication to ART
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
R. Scott McClelland, M.D, MPH
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
Women's Health Project, Mombasa
City
Mombasa
ZIP/Postal Code
254
Country
Kenya

12. IPD Sharing Statement

Citations:
PubMed Identifier
32779730
Citation
Palmer MJ, Henschke N, Villanueva G, Maayan N, Bergman H, Glenton C, Lewin S, Fonhus MS, Tamrat T, Mehl GL, Free C. Targeted client communication via mobile devices for improving sexual and reproductive health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013680. doi: 10.1002/14651858.CD013680.
Results Reference
derived

Learn more about this trial

Motivation Matters Study

We'll reach out to this number within 24 hrs